ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,868Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 247

$490K Total Retail Price of All Prescriptions

Rank: 44 out of 247

404 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 6,204 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LEVOTHYROXINE SODIUM 378 288 1 3
OMEPRAZOLE 346 250 2 4
LISINOPRIL 293 252 3 2
SIMVASTATIN 284 212 4 1
AMLODIPINE BESYLATE 277 268 5 6
FUROSEMIDE 233 199 6 5
ATORVASTATIN CALCIUM 222 214 7 8
HYDROCHLOROTHIAZIDE 217 190 8 9
SERTRALINE HCL 196 175 9 16
ALENDRONATE SODIUM 153 148 10 32
HYDROCODONE-ACETAMINOPHEN 148 89 S3 11 11
ZOLPIDEM TARTRATE 144 102 12 24
ATENOLOL 144 120 12 10
METFORMIN HCL 136 87 14 12
PANTOPRAZOLE SODIUM 134 85 15 19
PRAVASTATIN SODIUM 125 68 16 23
CITALOPRAM HBR 115 108 17 20
METOPROLOL TARTRATE 115 104 17 7
LOSARTAN POTASSIUM 113 101 19 15
TRAZODONE HCL 106 81 20 28
GABAPENTIN 106 66 20 17
WARFARIN SODIUM 101 94 22 13
SPIRIVA 100 78 23 26
PROAIR HFA 100 75 23 29
GLYBURIDE 99 79 R 25 41
CRESTOR 97 94 26 30
ADVAIR DISKUS 89 77 27 18
DIOVAN 78 78 28 38
METOPROLOL SUCCINATE 75 66 29 14
LOVASTATIN 74 64 30 22
CYMBALTA 68 24 31 52
PAROXETINE HCL 66 43 32 45
FAMOTIDINE 62 59 33 66
TRAMADOL HCL 61 44 34 25
FLUTICASONE PROPIONATE 58 51 35 37
NEXIUM 54 0 36 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 50 37 51
POTASSIUM CHLORIDE 53 38 37 36
NIFEDIPINE ER 50 46 39 233
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.